In Silico Molecular Interaction Studies of Suberoylanilide Hydroxamic Acid and Its Modified Compounds with Histones Deacetylase Class II <i>Homo sapiens</i> as Curative Measure towards Cervical Cancer

Journals Menu

Follow SCIRP

ISSN Print: 1947-3931
ISSN Online: 1947-394X
www.scirp.org/journal/eng
E-mail: eng@scirp.org

"In Silico Molecular Interaction Studies of Suberoylanilide Hydroxamic Acid and Its Modified Compounds with Histones Deacetylase Class II Homo sapiens as Curative Measure towards Cervical Cancer"
written by Usman Sumo Friend Tambunan, Arli Aditya Parikesit, Tirtana Prasetia, Djati Kerami,
published by Engineering, Vol.5 No.10B, 2013

has been cited by the following article(s):

[1]	Pharmacogenomics: Overview, Applications, and Recent Developments
	2020

[2]	Exposing the Molecular Screening Method of Indonesian Natural Products Derivate as Drug Candidates for Cervical Cancer (Summer 2017)
	2017

[3]	Exposing the Molecular Screening Method of Indonesian Natural Products Derivate as Drug Candidates for Cervical Cancer
	Iranian journal of pharmaceutical research: IJPR, 2017

[4]	In silico modification of Zn2+ binding group of suberoylanilide hydroxamic acid (SAHA) by organoselenium compounds as Homo sapiens class II HDAC inhibitor of cervical cancer
	IOP Conference Series: Materials Science and Engineering, 2016

[5]	The complexity of molecular interactions and bindings between cyclic peptide and inhibit polymerase A and B1 (PAC-PB1N) H1N1
	2015

[6]	Utilization of boron compounds for the modification of suberoyl anilide hydroxamic acid as inhibitor of histone deacetylase class II Homo sapiens
	Advances in Bioinformatics, 2014

[7]	Utilization of boron compounds for the modification of suberoyl anilide hydroxamic acid (SAHA) as inhibitor of histone deacetylase (HDAC) class II Homo sapiens
	2014

[8]	Utilization of boron compounds for the modification of suberoyl anilide hydroxamic acid (SAHA) as inhibitor of histone deacetylase (HDAC) class II Homo …


[9]	Biokimia dan Teknologi Farmasi: Desain Obat dan Vaksin dengan Pendekatan Biomedis Molekular

Follow SCIRP

[1]	Drug Design - Novel Advances in the Omics Field and Applications [Working Title] 2020 DOI:10.5772/intechopen.93737

[2]	Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class IIHomo sapiens Advances in Bioinformatics, 2014 DOI:10.1155/2014/104823